ОбзорГрафикПрофильОсновная статистикаФинансовые показателиНовостиTraderScreen

TEIJIN LTD/  JP3544000007  /

Frankfurt
12.11.2024  8:14:19 Изменение -0.1000 Объем сделки Бид8:14:22 Предложение8:14:22 Рыночная капитализация Дивидендная доходность Коэффициент Цена/Доход
8.1500EUR -1.21% 0
Оборот: 0.0000		 8.1500Величина цены спроса: 400 8.7000Величина цены предложения: 300 1.64 млрдEUR - -
TeleTrader 31.05 Blackstone reportedly to buy Japan's Infocom for $1.7B
GlobeNewswire 13.05 Significant and Sustained Improvements in Renal Function Reported for Adults with Chronic Hypoparath...
GlobeNewswire 09.05 Latest Clinical and Quality-of-Life Data for TransCon™ PTH (Palopegteriparatide)-Treated Adults with...
GlobeNewswire 14.02 Iktos opens a subsidiary in Japan and entrusts its management to Hideyoshi Fuji
GlobeNewswire 07.02 Ascendis Pharma Reports Fourth Quarter and Full Year 2023 Results
GlobeNewswire 31.01 Ascendis Pharma Launches 2nd TransCon™ Product: YORVIPATH® Now Available in Germany and Austria for ...
GlobeNewswire 07.01 Ascendis Pharma Introduces Vision 2030
GlobeNewswire 04.12.2023 NeuroStar TMS Receives Expanded Regulatory Approval in Japan
GlobeNewswire 29.11.2023 Ascendis Pharma Announces Strategic Partnership with Teijin Limited in Japan
GlobeNewswire 30.08.2023 Churchill Franklin Automotive Launches Airbag Alert News Service
Newsfile Corp 21.11.2022 The "Electrification" of the World: Battery Safety and Efficiency Demands Grow Amidst Lofty Global E...
GlobeNewswire 24.02.2022 Radius Health, Inc. Fourth Quarter & Full Year 2021 Results
GlobeNewswire 20.12.2021 CORRECTION - MassMEDIC Announces the 2021 IGNITE Accelerator Winners
GlobeNewswire 20.12.2021 MassMEDIC Announces the 2021 IGNITE Accelerator Winners
GlobeNewswire 02.06.2021 Radius Health Business Update
GlobeNewswire 25.03.2021 Calling Early Stage Medtech Start Ups: Apply Now for 2021 IGNITE
GlobeNewswire 24.03.2021 Radius Health Provides Update on Abaloparatide
GlobeNewswire 25.02.2021 Radius Health, Inc.: Fourth Quarter and Full Year Results
GlobeNewswire 12.02.2021 Radius Health, Inc. Provides Abaloparatide Business Update
GlobeNewswire 05.11.2020 Radius Health, Inc.: Third Quarter 2020 Operating Results
GlobeNewswire 21.10.2020 Radius Health, Inc.: Progress Since May 2020
GlobeNewswire 21.09.2020 NeuroSigma Receives Bridge Financing from Checkmate Capital
GlobeNewswire 09.09.2020 Radius Health Announces Scientific Presentations on abaloparatide at ASBMR 2020 Annual Meeting
GlobeNewswire 10.08.2020 Radius Health Announces Second Quarter 2020 Operating Results
GlobeNewswire 27.05.2020 Pivotal Phase III trial of abaloparatide-SC in Japanese women and men with osteoporosis achieves pri...